Cansativa

Cansativa Group is a German company founded in 2017 that specializes in the distribution of medical cannabis. The company operates as a pharmaceutical wholesaler, holding certifications for Good Distribution Practice (GDP) and licenses for handling controlled substances. It has established a business-to-business platform to manage the cannabis value chain, including logistics, and serves a network of thousands of pharmacies across Germany.

A significant aspect of Cansativa's business is its role as the exclusive partner of the German authorities for the distribution of domestically grown cannabis. This partnership underscores the company's position in the German medical cannabis market. In addition to its distribution services, Cansativa provides independent market access for cannabis products and maintains extensive warehousing capabilities.

The company also engages in educational efforts and provides resources for both doctors and patients. For medical professionals, it offers information on treatment options and the process of prescribing cannabis. For patients, it provides guidance on cost coverage, application procedures with health insurance, and the appeals process.

Cansativa's business model is centered on the importation, storage, licensing, and distribution of cannabis products. The company generates revenue through these wholesale and distribution activities, supplying pharmacies with medical cannabis for patients with prescriptions. It also engages in branding and bringing international cannabis products to the German market.

Keywords: medical cannabis, pharmaceutical wholesaler, B2B platform, cannabis distribution, German market, controlled substances, logistics, pharmacy network, GDP certified, patient resources